Entyvio

Entyvio (vedolizumab) is a prescription medication used to treat Ulcerative colitis, Crohn's disease. A gut-selective biologic for moderate-to-severe ulcerative colitis and Crohn's disease in adults.

Blocks integrin receptors that allow inflammatory white blood cells to migrate into the gut lining, reducing intestinal inflammation.

Commonly reported side effects of Entyvio include Respiratory infections, Headache, Joint pain, Nausea, and Liver problems. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Entyvio has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Entyvio.

The active ingredient in Entyvio is vedolizumab, which belongs to a class of medicines known as Integrin Receptor Antagonist (Biologic).

Entyvio is manufactured by Takeda. It was first approved in 2014.

You may be able to lower the cost of Entyvio by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.